The US Court of Appeals for the Federal Circuit has confirmed a prior ruling by the US District Court for the District of Delaware that the Eli Lilly and Company's compound patent for Alimta (pemetrexed) is valid. The compound patent ...
Eli Lilly and Company Alimta(pemetrexed for injection)has received FDA approval for new use in the continuation maintenance setting for advanced or metastatic nonsquamous non-small cell lung cancer(NS NSCLC). The approval was based on ...